References
- Steinmetz JD, Bourne RRA, Briant PS. Causes of blindness and vision impairment in. 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021;9(2):e144–e60. doi:10.1016/S2214-109X(20)30489-7
- Karen Allison DP, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020;12:11.
- Kang JM, Tanna AP. Glaucoma. Med Clin North Am. 2021;105(3):493–510. doi:10.1016/j.mcna.2021.01.004
- Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;14:121. doi:10.1186/1471-2415-14-121
- Wagner IV, Stewart MW, Dorairaj SK. Updates on the diagnosis and management of glaucoma. Mayo Clin Proc Innov Qual Outcomes. 2022;6(6):618–635. doi:10.1016/j.mayocpiqo.2022.09.007
- Conlon R, Saheb H, Ahmed II. Glaucoma treatment trends: a review. Can J Ophthalmol. 2017;52(1):114–124. doi:10.1016/j.jcjo.2016.07.013
- Harasymowycz P, Birt C, Gooi P, et al. Medical management of glaucoma in the 21st century from a Canadian perspective. J Ophthalmol. 2016;2016:6509809. doi:10.1155/2016/6509809
- Singh K, Shrivastava A. Medical management of glaucoma: principles and practice. Indian J Ophthalmol. 2011;59 Suppl(Suppl1):S88–92.
- Arora KS, Robin AL, Corcoran KJ, et al. Use of various glaucoma surgeries and procedures in medicare beneficiaries from 1994 to 2012. Ophthalmology. 2015;122(8):1615–1624. doi:10.1016/j.ophtha.2015.04.015
- Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–1911. doi:10.1001/jama.2014.3192
- Yao M, Kitayama K, Yu F, et al. Association between myopia and primary open-angle glaucoma by race and ethnicity in older adults in the California medicare population. JAMA Ophthalmol. 2023;141(6):525–532. doi:10.1001/jamaophthalmol.2023.1007
- Shao SC, Su YC, Lai EC, et al. Association between sodium glucose co-transporter 2 inhibitors and incident glaucoma in patients with type 2 diabetes: a multi-institutional cohort study in Taiwan. Diabetes Metab. 2022;48(1):101318. doi:10.1016/j.diabet.2022.101318
- Ehrenstein V, Petersen I, Smeeth L, et al. Helping everyone do better: a call for validation studies of routinely recorded health data. Clin Epidemiol. 2016;8:49–51. doi:10.2147/CLEP.S104448
- Biggerstaff KS, Frankfort BJ, Orengo-Nania S, et al. Validity of code based algorithms to identify primary open angle glaucoma (POAG) in Veterans Affairs (VA) administrative databases. Ophthalmic Epidemiol. 2018;25(2):162–168. doi:10.1080/09286586.2017.1378688
- Kang EM, Pinheiro SP, Hammad TA, Abou-Ali A. Evaluating the validity of clinical codes to identify cataract and glaucoma in the UK clinical practice research datalink. Pharmacoepidemiol Drug Saf. 2015;24(1):38–44. doi:10.1002/pds.3726
- Huerta C, Garcia Rodriguez LA, Moller CS, Arellano FM. The risk of obstructive airways disease in a glaucoma population. Pharmacoepidemiol Drug Saf. 2001;10(2):157–163. doi:10.1002/pds.567
- Kuo CY, Ko YC, Kuang TM, Chiou PM, Chiou SH, Liu CJ. Prevalence of glaucoma in the elderly population in Taiwan: The Shihpai Eye Study. J Chin Med Assoc. 2020;83(9) :880–884.
- Chan EW, Li X, Tham YC, et al. Glaucoma in Asia: regional prevalence variations and future projections. Br J Ophthalmol. 2016;100(1):78–85. doi:10.1136/bjophthalmol-2014-306102
- Shao SC, Chan YY, Kao Yang YH, et al. The chang gung research database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol Drug Saf. 2019;28(5):593–600. doi:10.1002/pds.4713
- Su YC, Hung JH, Chang KC, et al. Comparison of sodium-glucose cotransporter 2 inhibitors vs glucagonlike peptide-1 receptor agonists and incidence of dry eye disease in patients with type 2 diabetes in Taiwan. JAMA Network Open. 2022;5(9):e2232584. doi:10.1001/jamanetworkopen.2022.32584
- Shao SC, Chang KC, Lin SJ, et al. Differences in outcomes of hospitalizations for heart failure after SGLT2 inhibitor treatment: effect modification by atherosclerotic cardiovascular disease. Cardiovasc Diabetol. 2021;20(1):213. doi:10.1186/s12933-021-01406-3
- Chen HK, Shao SC, Weng MY, et al. Risk of heart failure in rheumatoid arthritis patients treated with tumor necrosis factor-alpha inhibitors. Clin Pharmacol Ther. 2021;110(6):1595–1603. doi:10.1002/cpt.2415
- Kang EY, Shao SC, Chang KC, et al. Real-world effectiveness of intravitreal dexamethasone implants - Comparison between eyes eligible and ineligible for clinical trials and their associated outcomes. Biomed J. 2024;47(1):100607. doi:10.1016/j.bj.2023.100607
- Su YC, Shao SC, Lai EC, et al. Risk of diabetic macular oedema with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients: a multi-institutional cohort study in Taiwan. Diabetes Obes Metab. 2021;23(9):2067–2076. doi:10.1111/dom.14445
- Wu Z, Medeiros FA. Recent developments in visual field testing for glaucoma. Curr Opin Ophthalmol. 2018;29(2):141–146. doi:10.1097/ICU.0000000000000461
- Chiang MY, Shao SC, Liao SC. Validation of diagnostic codes to identify carbon monoxide poisoning in taiwan’s claims data. Front Pharmacol. 2022;13:882632. doi:10.3389/fphar.2022.882632
- Chang C, Liao SC, Shao SC. Positive predictive values of anaphylaxis diagnosis in claims data: a multi-institutional study in Taiwan. J Med Sys. 2023;47(1):97. doi:10.1007/s10916-023-01989-2
- Anil Kumar Srivastava VKG, Ratnendra Kumar Misra. Significance of van herick test and its comparison with gonioscopy grading. Indian J Clinical Expe Ophthalmol. 2017;3(1):11–14.
- ICD-10 Glaucoma Reference Guide. American Glaucoma Societ American Acad Ophthalmol; 2015.
- Zhao Y, Fu JL, Li YL, et al. Epidemiology and clinical characteristics of patients with glaucoma: an analysis of hospital data between 2003 and 2012. Indian J Ophthalmol. 2015;63(11):825–831. doi:10.4103/0301-4738.171963
- Hong C, Hong SW, Park CK, et al. Profiles and clinical characteristics of newly diagnosed glaucoma in urban Korea: a multicenter study. Korean J Ophthalmol. 2020;34(5):353–360. doi:10.3341/kjo.2020.0033
- Lin MH, Chang HT, Chen TJ, Hwang SJ. Why people select the outpatient clinic of medical centers: a nationwide analysis in Taiwan. PeerJ. 2020;8:e9829. doi:10.7717/peerj.9829